C
CorpDigest
CompaniesIndustriesCompareBlogAbout
Search companiesSearchKContact

Novo Nordisk A/S

PharmaceuticalsFounded 1989
Reviewed by Swet Parvadiya
|
Last reviewed: July 2026
OverviewHistory & FailuresBusiness ModelFinancialsCompetitive StrategyFoundersCEO HistoryAcquisitions

Explore Novo Nordisk A/S

Core profile pages, annual revenue records, and related research hubs for this company.

Company profile

Novo Nordisk A/S OverviewNovo Nordisk A/S Company historyNovo Nordisk A/S Business modelNovo Nordisk A/S FinancialsNovo Nordisk A/S Competitive strategyNovo Nordisk A/S FoundersNovo Nordisk A/S CEO historyNovo Nordisk A/S Acquisitions

Revenue and founders

FY2025

Research hubs

All company profilesCompare companiesFounder directoryCorpDigest methodologyPharmaceuticals companiesDenmark company directory

Editorial guides

How companies make moneyLargest companies by revenueFastest-growing companiesWhat is a business moat?How to read a 10-K

Competitor research

NovartisBausch Health CompaniesEli Lilly
Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.
C
CorpDigest

Structured business intelligence for strategic research. Track 409 verified company profiles.

Strategic Resources

  • Full Directory
  • Compare Tools
  • About Mission
  • Founder Profile
  • Data Sources
  • Editorial Policy
  • Contact Desk
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • Home Base

Strategic Analyses

  • Apple vs Microsoft
  • Amazon vs Walmart
  • Google vs Meta
  • Netflix vs Spotify
  • Tesla vs Toyota
  • Nike vs Adidas
  • Coca-Cola vs PepsiCo
  • JPMorgan vs Bank of America
  • Visa vs Mastercard
  • Airbnb vs Marriott
  • Intel vs Nvidia
  • Uber vs Lyft
  • Disney vs Warner Bros
  • Salesforce vs ServiceNow
  • IBM vs Accenture
  • Boeing vs Airbus

© 2026 CorpDigest. Independent business research.

Companies/Novo Nordisk A/S/Revenue/FY2025

Annual Revenue

Novo Nordisk A/S Revenue in 2025

FY2025 Revenue

$46.0B

▲ 7.7% vs FY2024 ($42.7B)

Net Income: $15.2B

Source: Annual report / company filing

Novo Nordisk A/S reported $46.0B in revenue for fiscal year 2025. This represents a growth of 7.7% compared to the 2024 figure of $42.7B.

Novo Nordisk reported FY2025 net sales of DKK 309.064 billion and profit of DKK 102.434 billion, approximately $46.0 billion and $15.2 billion.

Revenue by Year

FY2025

Novo Nordisk A/S Annual Revenue History

YearRevenueNet IncomeYoY Change
FY2025$46.0B$15.2B+7.7%
FY2024$42.7B$14.3B+25.6%
FY2023$34.0B$12.2B—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Novo Nordisk A/S OverviewFull Financials →Company History →